X
XBIO
Xenetic Biosciences Inc
1.720
-0.210-10.88%After Hours: 1.700 -0.020 -1.16%16:00 10/23 EDT
OPEN/PREV CLOSE1.900/1.930
TODAY RANGE1.720-1.900
VOL22.12K
MARKET CAP4.03M
52 WEEK RANGE1.720-4.939
AVG VOL (3M)87.38K
% TURNOVER0.94%
TURNOVER--
P/E (TTM)-1.4325
% RANGE11.40%
EPS(TTM)-1.2007
P/E(FORWARD)-0.5181
P/B0.6636
BVPS2.592
DIVIDEND--
P/S1.324
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.40M
SHARES OUTSTANDING2.34M
NEXT EARNINGS11/10-11/16
FREE FLOAT1.98M
LOT SIZE1
EX-DATE05/15/2023
News
Press Releases
Financial Reports
Profile
TipRanks·10/15 12:50
Xenetic, PeriNess announce first patient dosed in DNase with CAR T cells study
Benzinga·10/05 12:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
TipRanks·09/23 21:48
Xenetic Updates Investors on Santersus Share Exchange Plans
Benzinga·09/22 17:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·09/16 17:05
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga·09/16 16:33
Crude Oil Down Over 3%; US Business Inventories Surge In July
Benzinga·09/16 14:28
Micro Cap Xenetic Biosciences Expands Therapeutic Platform With Santersus Acquisition
Benzinga·09/16 13:42
Nasdaq Gains Over 100 Points; US Retail Sales Beat Estimates
Benzinga·09/16 12:06
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Dow Jones·09/16 11:30
Xenetic Biosciences in Reverse Merger Pact With Santersus
TipRanks·09/16 11:27
Xenetic Biosciences to Acquire Santersus AG in Merger
TipRanks·09/16 11:10
Xenetic, Santerus enter definitive share exchange agreement
Dow Jones·09/16 11:09
*Xenetic Biosciences Shareholders to Own About 15% of Combined Company >XBIO